Stock Club

#263: European Stocks are Soaring, Here’s a Great One to Add to Your Portfolio


Listen Later

Bragging may be unbecoming, but Mike and Emmet are here to do just that.

As of this week, our international portfolio, Nexus II, is outperforming the S&P 500 by 20%. While macroeconomic uncertainty reigns in the U.S., international stocks are having a strong year. To celebrate, Mike walks you through the latest addition to Nexus II: Vitec Software Group.

It’s Swedish, growing rapidly, and resembles a young Constellation Software. What’s not to like?

The team has also prepared a research paper on why capital is moving abroad, whether this signals the end of American exceptionalism, and how it could shape your portfolio. It’ll be hitting your inbox in this week’s Stock Club newsletter—or you can request a copy here:

https://mywallst.com/the-sell-america-thesis

Later, Emmet unpacks three major biotech stories from around the world, including a powerful example of CRISPR technology in action.

If you’re looking for great international growth stocks to supercharge your portfolio, look no further than Nexus II.

Since its launch in November 2024, Nexus II has been trouncing the S&P 500.

To celebrate, we’re offering our loyal listeners a phenomenal discount—so good, we can’t share it publicly.

To claim your discount, email us at [email protected]

Become a successful investor by checking out all the content MyWallSt has to offer:

📩 Email us: [email protected]

📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7

💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/

🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/

🎉 Follow MyWallSt on social:

🐦 Twitter: @MyWallStHQ

💃 TikTok: @MyWallSt

📸 Instagram: @MyWallSt

🖥️ Facebook: @MyWallSt

👔 LinkedIn: MyWallSt


00:00 Intro

02:53 Nexus II: International Stock Picking Service

06:56 Spotlight on Vitec Software Group

26:05 Regeneron Acquires 23andMe

31:48 CRISPR's Breakthrough in Gene Editing

40:39 Electricity as a Medical Treatment


...more
View all episodesView all episodes
Download on the App Store

Stock ClubBy MyWallSt

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

98 ratings


More shows like Stock Club

View all
Motley Fool Money by The Motley Fool

Motley Fool Money

3,212 Listeners

We Study Billionaires - The Investor’s Podcast Network by The Investor's Podcast Network

We Study Billionaires - The Investor’s Podcast Network

3,377 Listeners

Rule Breaker Investing by The Motley Fool

Rule Breaker Investing

946 Listeners

Investing Insights by Morningstar

Investing Insights

522 Listeners

Best Stocks Now with Bill Gunderson by Bill Gunderson

Best Stocks Now with Bill Gunderson

353 Listeners

Zacks Market Edge by Zacks Investment Research

Zacks Market Edge

296 Listeners

The Meb Faber Show - Better Investing by The Idea Farm

The Meb Faber Show - Better Investing

948 Listeners

The Investing for Beginners Podcast - Your Path to Financial Freedom by By Andrew Sather and Dave Ahern | Stock Market Guide to Buying Stocks like

The Investing for Beginners Podcast - Your Path to Financial Freedom

1,420 Listeners

Chit Chat Stocks by Chit Chat Stocks

Chit Chat Stocks

196 Listeners

The Acquirers Podcast by Tobias Carlisle

The Acquirers Podcast

302 Listeners

The Long View by Morningstar

The Long View

919 Listeners

The Intrinsic Value Podcast - The Investor’s Podcast Network by The Investor's Podcast Network

The Intrinsic Value Podcast - The Investor’s Podcast Network

563 Listeners

Behind the Balance Sheet by Stephen Clapham's Podcast on Value Investing | Stockmarket Analysis | Equities

Behind the Balance Sheet

48 Listeners

Investing Experts by Seeking Alpha

Investing Experts

64 Listeners

Stock Market Today With IBD by Investor's Business Daily

Stock Market Today With IBD

52 Listeners